Pascal and Francis Bibliographic Databases

Help

Search results

Your search

au.\*:("BIRRER, Michael J")

Publication Year[py]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Discipline (document) [di]

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Author Country

A-Z Z-A Frequency ↓ Frequency ↑
Export in CSV

Results 1 to 25 of 56

  • Page / 3
Export

Selection :

  • and

AP-1 complexes containing cJun and JunB cause cellular transformation of Rat1a fibroblasts and share transcriptional targetsLEANER, Virna D; KINOSHITA, Ichiro; BIRRER, Michael J et al.Oncogene (Basingstoke). 2003, Vol 22, Num 36, pp 5619-5629, issn 0950-9232, 11 p.Article

In situ detection of unexpected patterns of mutant p53 gene expression in non-small cell lung cancersEBINA, Masahito; MARTINEZ, Alfredo; BIRRER, Michael J et al.Oncogene (Basingstoke). 2001, Vol 20, Num 20, pp 2579-2586, issn 0950-9232Article

Early Events in the Pathogenesis of Epithelial Ovarian CancerLANDEN, Charles N; BIRRER, Michael J; SOOD, Anil K et al.Journal of clinical oncology. 2008, Vol 26, Num 6, pp 995-1005, issn 0732-183X, 11 p.Article

Ovarian Cancer Risk Associated with Inherited Inflammation-Related VariantsWHITE, Kristin L; SCHILDKRAUT, Joellen M; BIRRER, Michael J et al.Cancer research (Chicago, Ill.). 2012, Vol 72, Num 5, pp 1064-1069, issn 0008-5472, 6 p.Article

The Role of KRAS rs61764370 in Invasive Epithelial Ovarian Cancer: Implications for Clinical TestingPHAROAH, Paul D. P; PALMIERI, Rachel T; BECKMANN, Matthias W et al.Clinical cancer research (Print). 2011, Vol 17, Num 11, pp 3742-3750, issn 1078-0432, 9 p.Article

Increased HLA-DMB Expression in the Tumor Epithelium Is Associated with Increased CTL Infiltration and Improved Prognosis in Advanced-Stage Serous Ovarian CancerCALLAHAN, Michael J; NAGYMANYOKI, Zoltan; BERKOWITZ, Ross S et al.Clinical cancer research (Print). 2008, Vol 14, Num 23, pp 7667-7673, issn 1078-0432, 7 p.Article

Synthesis of flexible sulfur-containing heteroarotinoids that induce apoptosis and reactive oxygen species with discrimination between malignant and benign cellsSHENGQUAN LIU; BROWN, Chad W; BERLIN, K. Darrell et al.Journal of medicinal chemistry (Print). 2004, Vol 47, Num 4, pp 999-1007, issn 0022-2623, 9 p.Article

Whole genome expression profiling of advance stage papillary serous ovarian cancer reveals activated pathwaysDONNINGER, Howard; BONOME, Tomas; RADONOVICH, Mike et al.Oncogene (Basingstoke). 2004, Vol 23, Num 49, pp 8065-8077, issn 0950-9232, 13 p.Article

The c-Jun NH2-terminal protein kinase/AP-1 pathway is required for efficient apoptosis induced by vinblastinelMEIYUN FAN; GOODWIN, Mary E; BIRRER, Michael J et al.Cancer research (Baltimore). 2001, Vol 61, Num 11, pp 4450-4458, issn 0008-5472Article

Risk Prediction for Late-Stage Ovarian Cancer by Meta-analysis of 1525 Patient SamplesRIESTER, Markus; WEI WEI; BIRRER, Michael J et al.Journal of the National Cancer Institute. 2014, Vol 106, Num 5, issn 0027-8874, dju048.1-dju048.12Article

BRCA Mutation Frequency and Patterns of Treatment Response in BRCA Mutation―Positive Women With Ovarian Cancer: A Report From the Australian Ovarian Cancer Study GroupALSOP, Kathryn; FEREDAY, Sian; FRIEDLANDER, Michael et al.Journal of clinical oncology. 2012, Vol 30, Num 21, pp 2654-2663, issn 0732-183X, 10 p.Article

Matrilysin-1 Mediates Bronchiolization of Alveoli, a Potential Premalignant Change in Lung CancerWANG, Xiao-Yang; DEMELASH, Abeba; KIM, Heungnam et al.The American journal of pathology. 2009, Vol 175, Num 2, pp 592-604, issn 0002-9440, 13 p.Article

Expression profiling of mucinous tumors of the ovary identifies genes of clinicopathologic importanceWAMUNYOKOLI, Fred W; BONOME, Tomas; MOK, Samuel et al.Clinical cancer research. 2006, Vol 12, Num 3, pp 690-700, issn 1078-0432, 11 p., 1Article

Gene expression profiles associated with response to chemotherapy in epithelial ovarian cancersJAZAERI, Amir A; AWTREY, Christopher S; BARRETT, J. Carl et al.Clinical cancer research. 2005, Vol 11, Num 17, pp 6300-6310, issn 1078-0432, 11 p.Article

Cyclin E amplification and overexpression in clear cell adenocarcinoma of the ovaryTSUDA, Hiroshi; BANDERA, Christina A; BIRRER, Michael J et al.Oncology. 2004, Vol 67, Num 3-4, pp 291-299, issn 0030-2414, 9 p.Article

Lovastatin induces apoptosis in a primitive neuroectodermal tumor cell line in association with RB down-regulation and loss of the G1 checkpointKIM, Jung-Sik; PIRNIA, Farzaneh; MUSHINSKI, J. Frederic et al.Oncogene (Basingstoke). 2000, Vol 19, Num 52, pp 6082-6090, issn 0950-9232Article

Reversible regulation of the transformed phenotype of ornithine decarboxylase-and ras-overexpressing cells by dominant-negative mutants of c-JunKIELOSTO, Mari; NUMMELA, Pirjo; KATAINEN, Riikka et al.Cancer research (Baltimore). 2004, Vol 64, Num 11, pp 3772-3779, issn 0008-5472, 8 p.Article

Thymosin β4 is a determinant of the transformed phenotype and invasiveness of S-adenosylmethionine decarboxylase -transfected fibroblastsNUMMELA, Pirjo; MIAO YIN; KIELOSTO, Mari et al.Cancer research (Baltimore). 2006, Vol 66, Num 2, pp 701-712, issn 0008-5472, 12 p.Article

Activity of Sorafenib in Recurrent Ovarian Cancer and Primary Peritoneal Carcinomatosis: A Gynecologic Oncology Group TrialMATEI, Daniela; SILL, Michael W; PETRICOIN, Emanuel F et al.Journal of clinical oncology. 2011, Vol 29, Num 1, pp 69-75, issn 0732-183X, 7 p.Article

LIN28B Polymorphisms Influence Susceptibility to Epithelial Ovarian CancerPERMUTH-WEY, Jennifer; KIM, Donghwa; CRAMER, Daniel W et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 11, pp 3896-3903, issn 0008-5472, 8 p.Article

MicroRNA Processing and Binding Site Polymorphisms Are Not Replicated in the Ovarian Cancer Association ConsortiumPERMUTH-WEY, Jennifer; ZHIHUA CHEN; FENSTERMACHER, David et al.Cancer epidemiology, biomarkers & prevention. 2011, Vol 20, Num 8, pp 1793-1797, issn 1055-9965, 5 p.Article

Wnt5a Suppresses Epithelial Ovarian Cancer by Promoting Cellular SenescenceBITLER, Benjamin G; NICODEMUS, Jasmine P; RUGANG ZHANG et al.Cancer research (Chicago, Ill.). 2011, Vol 71, Num 19, pp 6184-6194, issn 0008-5472, 11 p.Article

NORE1A Tumor Suppressor Candidate Modulates p21 CIP1 via p53CALVISI, Diego F; DONNINGER, Howard; VOS, Michele D et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 11, pp 4629-4637, issn 0008-5472, 9 p.Article

Expression profiling identifies altered expression of genes that contribute to the inhibition of transforming growth factor-β signaling in ovarian cancerSUNDE, Jan S; DONNINGER, Howard; KONGMING WU et al.Cancer research (Baltimore). 2006, Vol 66, Num 17, pp 8404-8412, issn 0008-5472, 9 p.Article

Current challenges and opportunities for research on Borderline Ovarian TumorsSHERMAN, Mark E; BERMAN, Jules; BIRRER, Michael J et al.Human pathology. 2004, Vol 35, Num 8, pp 961-970, issn 0046-8177, 10 p.Conference Paper

  • Page / 3